In the press
IF HENRY FORD WERE IN BIOTECH
IF HENRY FORD WERE IN BIOTECH
Please join us to hear from our CEO, Marc Appel.
Related Press
Wall Street Journal
Wall Street Journal The following was taken from the Wall Street Journal. Check out the original piece here: https://www.wsj.com/articles/vc-daily-biotechs-test-new-company-building-model-11614261635 We are incredibly excited and humbled to be recognized in the Wall Street Journal for our innovative business model! We thank everyone who has been supporting us from the beginning.
Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships
Collaborations with Yonsei University Health System and Pohang University of Science and Technology Designed to Strengthen Biotech Entrepreneurial Ecosystem in South Korea The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) — Orange Grove Bio, a
New Podcast Launched
We are ecstatic to announce that we have launched our new podcast “OGB Podcast” on both Spotify and Anchor. We will be talking to industry leaders about the state of the biotech industry as well as delving into the specifics of our guests expertise. You can find and listen to us on Spotify ( https://open.spotify.com/show/0tSRtB4tFUcqHhW43RkWIL
Orange Grove Bio: Filling the Gap in Preclinical Drug Development
Orange Grove Bio is a preclinical drug development company focused on driving down the cost of drug development… Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of a collaboration Orange Grove Bio is a preclinical drug development company focused on driving down the cost
New York biotech firm moving HQ to Cincinnati
New York biotech firm moving HQ to Cincinnati The following excerpt was taken from Cincyinno Business Journal — continue reading here. A New York-based biotech firm is moving its corporate headquarters to the University of Cincinnati’s 1819 Innovation Hub “A New York-based biotech firm is moving its corporate headquarters to the University of Cincinnati’s 1819
IpiNovyx Bio Awarded NIH Catalyze Award to Advance Novel Proteasome Therapeutic for Systemic Sclerosis-Associated Interstitial Lung Disease
Funding to Support Preclinical Development of First-in-Class Inhaled Therapy Targeting Lung Inflammation and Fibrosis Cincinnati, OH, May 11, 2026 — IpiNovyx Bio, a biotechnology company developing best-in-class proteasome modulating therapeutics, and launched by Orange Grove Bio, today announced it has been selected to receive support from the National Heart, Lung, and Blood Institute’s (NHLBI) Catalyze
Orange Grove Bio Closes on New Financing Round to Advance Strategic Initiatives and Welcomes Salvatore Cremona as New Chief Executive Officer
CINCINNATI, OH, August 12, 2025 – Orange Grove Bio, a biotech holding company focused on transforming and developing early, innovative ideas into pharma-ready therapies announces today that it has closed on a new round of financing led by a consortium of investors based in Denver, Colorado and effective immediately upon close Salvatore Cremona has been
Thani Al Zeyoudi attends World Investment Forum to accelerate investment in high-potential markets
The following excerpt was taken from dailyhunt.me — continue reading here. ABU DHABI, 19th October, 2023 (WAM) – Dr Thani bin Ahmed Al Zeyoudi, UAE Minister of State for Foreign Trade, has held a series of high-level meetings with global ministers on the fourth day of the 8th World Investment Forum (WIF), during which he
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science
Partnership represents firm’s second international collaboration and provides access to groundbreaking research taking place within world’s fifth largest pharmaceutical market The following excerpt was taken from GlobeNewswire – continue reading here. CINCINNATI, January 31, 2023 (GLOBE NEWSWIRE) – Orange Grove Bio, a drug investment and development firm, today announced that it has established a new